Form D Explorer

Form C — 20/20 Biolabs, Inc.

0001670254-24-000551 · filed 2024-05-06 · via Wefunder Portal LLC

Offering

Target: $50,000
Maximum: $5,000,000
Security type: Preferred Stock
Price per security: $5.3400
Deadline: —
Oversubscription: Accepted

Issuer

Name: 20/20 Biolabs, Inc.
CIK: 1139685
Entity: Corporation
Jurisdiction: DE
Address: 15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877
Phone: —

Most recent fiscal year financials

Total assets

$6,367,828

Cash

—

Short-term debt

$1,011,623

Long-term debt

$1,068,713

Revenues

$1,424,304

COGS

$1,315,166

Taxes paid

—

Net income

$-6,391,309

Same issuer's Form D filings

D · 2025-02-26

$3M

View original on SEC EDGAR.